Association between anemia and multiple sclerosis. 2015

Tatiana Koudriavtseva, and Rosaria Renna, and Domenico Plantone, and Chiara Mandoj, and Maria Cristina Piattella, and Diana Giannarelli

OBJECTIVE The relationship between multiple sclerosis (MS) and anemia has not been clarified sufficiently. In this retrospective, cross-sectional, case-control study we evaluated in MS patients: (1) prevalence of anemia relative to sex- and age-matched controls; (2) relationships between patients' demographic, clinical and drug-related characteristics and anemia; (3) effect of anemia on the risk of developing MS. METHODS 187 consecutive MS patients (51 males, mean age (±SD) 44.5 ± 10.7 years) and 200 controls (56 males, mean age 45.5 ± 12 years) were included in the study. Anemia was defined as hemoglobin <12 g/dl for females and <13 g/dl for males. RESULTS There was a significant difference in the prevalence of anemia between MS patients and controls (35 (18.7%) and 19 (9.5%), respectively, p = 0.009). We did not find any association between patients' characteristics and anemia. The occurrence of anemia increased more than twice the risk of developing MS (odds ratio: 2.19, 95% confidence interval 1.19-4.0). CONCLUSIONS Our study showed a consistent association between anemia and MS.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000740 Anemia A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN. Anemias

Related Publications

Tatiana Koudriavtseva, and Rosaria Renna, and Domenico Plantone, and Chiara Mandoj, and Maria Cristina Piattella, and Diana Giannarelli
September 1979, Journal of neurology, neurosurgery, and psychiatry,
Tatiana Koudriavtseva, and Rosaria Renna, and Domenico Plantone, and Chiara Mandoj, and Maria Cristina Piattella, and Diana Giannarelli
January 1992, Developments in ophthalmology,
Tatiana Koudriavtseva, and Rosaria Renna, and Domenico Plantone, and Chiara Mandoj, and Maria Cristina Piattella, and Diana Giannarelli
January 1975, Progress in medical virology. Fortschritte der medizinischen Virusforschung. Progres en virologie medicale,
Tatiana Koudriavtseva, and Rosaria Renna, and Domenico Plantone, and Chiara Mandoj, and Maria Cristina Piattella, and Diana Giannarelli
November 2016, European journal of epidemiology,
Tatiana Koudriavtseva, and Rosaria Renna, and Domenico Plantone, and Chiara Mandoj, and Maria Cristina Piattella, and Diana Giannarelli
January 2024, Endocrine, metabolic & immune disorders drug targets,
Tatiana Koudriavtseva, and Rosaria Renna, and Domenico Plantone, and Chiara Mandoj, and Maria Cristina Piattella, and Diana Giannarelli
October 2007, Internal medicine journal,
Tatiana Koudriavtseva, and Rosaria Renna, and Domenico Plantone, and Chiara Mandoj, and Maria Cristina Piattella, and Diana Giannarelli
January 2017, Survey of ophthalmology,
Tatiana Koudriavtseva, and Rosaria Renna, and Domenico Plantone, and Chiara Mandoj, and Maria Cristina Piattella, and Diana Giannarelli
June 2006, European journal of neurology,
Tatiana Koudriavtseva, and Rosaria Renna, and Domenico Plantone, and Chiara Mandoj, and Maria Cristina Piattella, and Diana Giannarelli
December 1981, Italian journal of neurological sciences,
Tatiana Koudriavtseva, and Rosaria Renna, and Domenico Plantone, and Chiara Mandoj, and Maria Cristina Piattella, and Diana Giannarelli
July 1993, Journal of neurology,
Copied contents to your clipboard!